Systematic Review: Diagnostic Accuracy of Clinical Decision Rules for Venous Thromboembolism in Elderly Publication Systematic Review: Diagnostic Accuracy of Clinical Decision Rules for Venous Thromboembolism in Elderly Physicians committed to the care of elderly patients are challenged with the diagnosis of venous…CertaraApril 1, 2011
Sources of Interindividual Variability in IVIVE of Clearance: An Investigation into the Prediction of Benzodiazepine Clearance Using a Mechanistic Population-based Pharmacokinetic Model Publication Sources of Interindividual Variability in IVIVE of Clearance: An Investigation into the Prediction of Benzodiazepine Clearance Using a Mechanistic Population-based Pharmacokinetic Model Prediction of metabolic clearance in extreme individuals rather than the 'average human' is becoming an…CertaraMarch 24, 2011
Utility of Intersystem Extrapolation Factors in Early Reaction Phenotyping and the Quantitative Extrapolation of Human Liver Microsomal Intrinsic Clearance Using Recombinant Cytochromes P450 Publication Utility of Intersystem Extrapolation Factors in Early Reaction Phenotyping and the Quantitative Extrapolation of Human Liver Microsomal Intrinsic Clearance Using Recombinant Cytochromes P450 Reaction phenotyping using recombinant human cytochromes P450 (P450) has great utility in early discovery. However,…CertaraMarch 1, 2011
Casopitant: In Vitro Data and Simcyp Simulation to Predict In Vivo Metabolic Interactions Involving Cytochrome P450 3A4 Publication Casopitant: In Vitro Data and Simcyp Simulation to Predict In Vivo Metabolic Interactions Involving Cytochrome P450 3A4 has previously been shown to be a potent and selective antagonist of the human neurokinin-1…CertaraMarch 1, 2011
Modeling and Predicting Drug Pharmacokinetics in Patients with Renal Impairment Publication Modeling and Predicting Drug Pharmacokinetics in Patients with Renal Impairment Current guidance issued by the US FDA to assess the impact of renal impairment on…CertaraMarch 1, 2011
Resurgence in the Use of Physiologically-based Pharmacokinetic Models in Pediatric Clinical Pharmacology: Parallel Shift in Incorporating the Knowledge of Biological Elements and Increased Applicability to Drug Development and Clinical Practice Publication Resurgence in the Use of Physiologically-based Pharmacokinetic Models in Pediatric Clinical Pharmacology: Parallel Shift in Incorporating the Knowledge of Biological Elements and Increased Applicability to Drug Development and Clinical Practice This study had two primary aims: (i) To describe an example of the development work…CertaraMarch 1, 2011
Physiologically-based Pharmacokinetic Model for Topotecan in Mice Publication Physiologically-based Pharmacokinetic Model for Topotecan in Mice Topotecan is a chemotherapeutic agent of choice for the second-line treatment of recurrent ovarian cancer.…CertaraFebruary 1, 2011
Excretion of the Principal Urinary Metabolites of Phenytoin and Absolute Oral Bioavailability Determined by Use of a Stable Isotope in Patients with Epilepsy Publication Excretion of the Principal Urinary Metabolites of Phenytoin and Absolute Oral Bioavailability Determined by Use of a Stable Isotope in Patients with Epilepsy The anticonvulsant properties of phenytoin (PHT) were discovered in 1938. Since then, it has been…CertaraFebruary 1, 2011
Poor Correlation between Urinary Excretion of the Principal Urinary Metabolites of Phenytoin and Absolute Oral Bioavailability Determined by a Stable Isotope Method in Epilepsy Patients Publication Poor Correlation between Urinary Excretion of the Principal Urinary Metabolites of Phenytoin and Absolute Oral Bioavailability Determined by a Stable Isotope Method in Epilepsy Patients The anticonvulsant properties of phenytoin (PHT) were discovered in 1938. Since then, it has been…CertaraFebruary 1, 2011
Physiologically-based Pharmacokinetics in Drug Development and Regulatory Science Publication Physiologically-based Pharmacokinetics in Drug Development and Regulatory Science The application of physiologically-based pharmacokinetic (PBPK) modeling is coming of age in drug development and…CertaraFebruary 1, 2011